The ACTA Trial of the Year Awards were established in 2016 and has been traditionally celebrated in International Clinical Trials day in May, as part of a National Tribute and Awards Ceremony. In 2020, the awards were delayed due to COVID-19, and are instead being presented as part of the opening of the Summit.
The awards honour the remarkable Australians who advance our health system by designing, conducting or participating in ground-breaking clinical trials, and promote the importance of clinical trials and the expertise and complexity of work involved. Trials considered for the award are collaboratively developed, multicentre, investigator-driven randomised controlled trials that were designed to improve patient-centred outcomes or healthcare delivery.
In 2020, eleven applications were received for the main Trial of the Year Award, as below. There are currently three main awards and we aim to add further awards in 2021, to recognise industry collaboration and clinical quality registries.
The 2020 ACTA Trial of the Year, ACTA STInG Excellence in Trial Statistics Award and the ACTA Consumer Involvement Awards, will be announced at the the ACTA Summit 2020 on 1 December, 2020, and we hope you will join us.
Registration for the Awards Ceremony and Summit and the live stream of the ceremony has now closed.
Watch the official opening of the 2020 ACTA Summit: Minister’s Address
Sponsors
We are very grateful to the continued support of our event sponsors.
- Gold Sponsors
- NSW Office for Health and Medical Research
- Bellberry Limited
- Clinical Trials 2020: National Tribute and Awards Ceremony Sponsor
- Medicines Australia
- Session Sponsor
- MTPConnect

Latest Resources
-
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry – Environmental Scan
-
HEAT Webinar Recording- Use of Administrative Data for Measuring Events and Healthcare Use
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
ACTA Whistleblower Policy
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018-2019
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
What a trialist should know about implementation to practice
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
Latest Events
-
Sector consultations – online discussion with ACTA
-
Economic Evaluation Alongside Adaptive Trials webinar – 22 November
-
2022 ACTA ASM including the Australian Registry ASM
-
Improving clinical trial recruitment through innovative technologies
-
Clinical Quality Registries (CQR) SIG member webinar – Oct 2022
-
ACTA CEO update – October 2022
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
ACTA CEO update – August 2022
-
Economic evaluation alongside cluster trial webinar
-
Clinical Trials (CT) Socials
-
Clinical Trials 2022: National Tribute and Awards
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
ACTA Advisory Council Meeting
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
Continuity of Care Collaboration (CCC) Forum – Rural and Remote Health
-
ACTA Annual General Meeting
-
ACTA Advisory Council
-
ACTA International Clinical Trials Conference 2 – 5 October 2019
-
ARDC HeSANDA Australian Data Partnerships Program: Open Call